COVID-19 Information
EpiVax, Inc., is using advanced computational tools to accelerate a COVID-19 vaccine candidate (EPV-CoV19) for healthcare workers (HCW) into clinical trials in 6 months. EpiVax has announced its partnership with GAIA Vaccine Foundation (“GVF”) to crowd-source funds for the project and its pledge to make a free license available to developing countries who qualify, in the context of this partnership.
COVID-19 Coverage (multiple press releases). https://epivax.com/home/vaccine-services/covid-19
Stage
Pre-clinical
Company Type
Vaccine